Genpact LTD Form 4 insider transactions

Genpact Senior Vice President Riju Vashisht reported the sale of 26,749 common shares, including tax-related withholdings, under a pre-arranged 10b5-1 trading plan.

Genpact's Senior Vice President and CHRO, Piyush Mehta, reported the withholding of 12,317 common shares for tax obligations following the vesting of restricted share units.

Genpact's Chief Financial Officer, Michael Hal Weiner, reported the disposition of 12,029 common shares for tax withholding purposes related to restricted share unit vesting.

Genpact's SVP and Chief Legal Officer, Sydney Schaub, was granted 63,357 unvested restricted share units under the company's incentive plan.

Genpact's President and CEO, Balkrishan Kalra, was granted 125,130 unvested restricted share units, increasing his beneficial ownership to 420,376 common shares.

Genpact's Chief Financial Officer, Michael Hal Weiner, reported the sale of 13,365 common shares at a weighted average price of $44.84.

Genpact's SVP & Chief Legal Officer, Heather White, reported multiple transactions involving the exercise of stock options and subsequent sale of common shares in November 2025.

Genpact Senior Vice President Sameer Dewan sold 26,531 common shares for approximately $1.18 million in a pre-arranged transaction.

Genpact Director Tamara Franklin sold 2,750 common shares at $45.65 per share, reducing her direct beneficial ownership to 22,236 shares.

Genpact's Chief Accounting Officer, Anthony J. Radesca, was granted 20,066 unvested restricted share units under the company's incentive plan.

Genpact's Senior Vice President and CHRO, Piyush Mehta, exercised stock options and subsequently sold a portion of his common shares for a profit.

Genpact's President and CEO, Balkrishan Kalra, exercised stock options and subsequently sold a portion of his common shares.

Genpact's Chief Accounting Officer, Donald J. Klunk, reported the disposition of common shares through tax withholding and open market sales.

Genpact Senior Vice President Sameer Dewan sold 20,078 common shares for $45 each in a pre-planned transaction.

Genpact Senior Vice President Anil Nanduru sold a total of 27,962 common shares over two days in August 2025, pursuant to a Rule 10b5-1 trading plan.

Genpact Senior Vice President Riju Vashisht reported the sale of 25,539 common shares through a pre-arranged Rule 10b5-1 plan.

Genpact Director Carol Lindstrom reported a planned sale of 2,326 common shares at $43.17 per share, reducing her direct holdings to 21,185 shares.

Genpact Director Thimaya K. Subaiya was granted 2,020 unvested restricted share units, vesting on December 31, 2025, and settling on December 31, 2026.

Genpact Limited's Director, John M. Hinshaw, was granted 2,334 unvested restricted share units, aligning his interests with shareholders through future equity ownership.

Genpact LTD Director Nicholas C. Gangestad has reported the acquisition of 1,988 common shares, increasing his beneficial ownership to 8,813 shares.

Genpact LTD Director Laura Conigliaro has been granted 4,825 unvested restricted share units (RSUs) as part of the company's 2017 Omnibus Incentive Compensation Plan, aligning her interests with shareholder value.

Genpact Ltd. Director Nicholas C. Gangestad has been granted 4,825 unvested restricted share units (RSUs) as part of the company's incentive compensation plan, aligning his interests with shareholder value.

Genpact Director Tamara Franklin was granted 4,825 unvested restricted share units, increasing her beneficial ownership to 24,986 common shares.

Genpact LTD Director Carol Lindstrom was granted 4,825 unvested restricted share units (RSUs) as part of the company's 2017 Omnibus Incentive Compensation Plan.

Genpact LTD Director Ajay Agrawal has been granted 4,825 unvested restricted share units (RSUs) as part of the company's 2017 Omnibus Incentive Compensation Plan.

Genpact LTD Director Brian Mark Stevens was granted 4,825 unvested restricted share units (RSUs) on May 22, 2025, as part of the company's incentive compensation plan.

Genpact LTD Director CeCelia Morken has been granted 4,825 unvested restricted share units (RSUs) as part of the company's 2017 Omnibus Incentive Compensation Plan.

Genpact Director Mark Verdi has been granted 4,825 unvested restricted share units, which will vest by December 31, 2025, and settle in common shares by December 31, 2026.

Genpact LTD Director James C. Madden was granted 7,582 unvested restricted share units, increasing his beneficial ownership to 63,068 common shares.

Director Nicholas C. Gangestad reports the acquisition of 2,000 common shares of Genpact LTD on May 13, 2025.